Latest Breaking News On - Homology medicines company profile - Page 1 : comparemela.com

Homology Medicines (NASDAQ:FIXX) Stock Price Down 2 7%

Shares of Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) fell 2.7% on Monday . The company traded as low as $1.04 and last traded at $1.08. 199,271 shares were traded during mid-day trading, a decline of 1% from the average session volume of 200,355 shares. The stock had previously closed at $1.11. Analysts Set […]

Robertw bairdRaymond james associatesHomology medicines company profileVirtu financialHomology medicines incMarshall waceMirabella financial servicesHomology medicinesGet free reportHomology medicines dailyNasdaq fixx

Homology Medicines, Inc (NASDAQ:FIXX) Short Interest Up 9 2% in July

Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) was the target of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 285,800 shares, a growth of 9.2% from the June 30th total of 261,800 shares. Currently, 0.7% of the company’s shares are sold short. […]

Robertw bairdMarshall waceCubist systematic strategiesHomology medicines incRaymond james associatesHomology medicines company profileVirtu financialMirabella financial servicesHomology medicinesGet free reportChardan capitalFinancial servicesSystematic strategiesHomology medicines daily

Homology Medicines, Inc to Post FY2023 Earnings of ($1 62) Per Share, Chardan Capital Forecasts (NASDAQ:FIXX)

Homology Medicines, Inc to Post FY2023 Earnings of ($1 62) Per Share, Chardan Capital Forecasts (NASDAQ:FIXX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Homology medicines incBlackrock incDimensional fund advisorsRaymond james associatesRenaissance technologiesHomology medicines company profileHomology medicinesFree reportChardan capitalHomology medicineGet free reportFund advisorsState street corpStreet corpHomology medicines daily

Homology Medicines, Inc (NASDAQ:FIXX) Receives $8 73 Consensus Target Price from Brokerages

Homology Medicines, Inc. (NASDAQ:FIXX – Get Rating) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price […]

Borough of bedfordUnited kingdomRaymond james associatesHomology medicines company profileMirabella financial servicesVirtu financialMarshall waceHomology medicines incCubist systematic strategiesHomology medicinesGet ratingMarketbeat ratingsFinancial servicesSystematic strategiesHomology medicines dailyNasdaq fixx